Effect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.

dc.contributor.affiliationAmsterdam UMC, University of Amsterdam, Institute for Infection and Immunity, Amsterdam, the Netherlands.
dc.contributor.affiliationEnteric Diseases and Vaccine Research Unit, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
dc.contributor.affiliationDepartment of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.
dc.contributor.affiliationUniversity of Zambia, School of Health Sciences, Lusaka, Zambia.
dc.contributor.authorLuchen CC
dc.contributor.authorMwaba J
dc.contributor.authorNg'ombe H
dc.contributor.authorAlabi PIO
dc.contributor.authorSimuyandi M
dc.contributor.authorChilyabanyama ON
dc.contributor.authorHatyoka LM
dc.contributor.authorMubanga C
dc.contributor.authorBosomprah S
dc.contributor.authorChilengi R
dc.contributor.authorChisenga CC
dc.date.accessioned2025-05-23T11:40:53Z
dc.date.issued2021
dc.description.abstractBACKGROUND: We set out to assess the impact of human immunodeficiency virus (HIV) and micronutrient deficiency as indicated by serum retinol levels on the immune responses to Oral Cholera Vaccine (Shanchol™) in a cohort of participants in Lukanga Swamps, Zambia. Cholera remains endemic in Zambia with vaccines being the only effective preventive measures. However, the effect of these vaccines on populations living with HIV has not been widely documented. METHODS: HIV testing and confirmation was done using the Alere Determine™ HIV-1/2 and Uni-Gold™ kits while vibriocidal antibody assay was applied for vaccine immunogenicity. Serum retinol analysis was assessed by Shimadzu Prominence HCT-2010 High Performance Liquid Chromatography (HPLC). The primary outcome was log transformed geometric mean titre. RESULTS: From 47 participants screened for HIV, 51% (24) tested positive. There was a statistically significant reduction in Ogawa geometric mean ratio (GMR) by 67% (GMR = 0.33; 95% CI: -0.15, 0.76; p-value = 0.009) attributable to HIV positivity with a non-significant reduction in Inaba GMR by about 50% due to HIV positivity. When doubling of retinol levels modelled, GMR reduction against Ogawa were non-significant but that against Inaba resulted in a significant reduction in geometric mean titer (GMT) (GMT-0.33, C.I 0.16-0.66, p-value 0.002). At 1000copies/ml viral load cut off and 350 cells/μl CD4 counts, Ogawa GMT was two times higher 11.16 (95%CI: 8.20-15.19) versus 6.06 (95%CI: 4.04-9.10) in low viremia participants, and three times higher in above threshold CD4 count participants; 24.81 (95%CI: 18.94-32.50) versus 7.07 (95%CI: 5.22-9.58). CONCLUSION: Our results show that while Shanchol™ is immunogenic in both HIV+/- individuals, HIV + participants responded poorly. Viral load and CD4 count affected vaccine immunogenicity. More research is required for detailed understanding of this in order to appropriately inform policy and practice.
dc.identifier.doi10.1371/journal.pone.0260552
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/10331
dc.sourcePloS one
dc.titleEffect of HIV status and retinol on immunogenicity to oral cholera vaccine in adult population living in an endemic area of Lukanga Swamps, Zambia.

Files

Collections